Award
NIH Reporter #1SB1CA301959-01A1
Preparing IND filing for novel lung cancer therapeutic
Recipient
Quench Medical, Inc.
Award Amount
$249,815.00
Ceiling
$249,815.00
Awarded
August 28, 2025
Identifier
1SB1CA301959-01A1
Award to Quench Medical, Inc. to develop a novel inhaled chemotherapy treatment for lung cancer, completing regulatory data for IND filing to the FDA, with a focus on improving survival and reducing toxicity.
Description
This project aims to develop a novel inhaled chemotherapy treatment for lung cancer, with the goal of improving survival rates and reducing systemic toxicity. The project will complete regulatory data for IND filing of QM-269 to the FDA, advancing a targeted dry powder aerosol formulation for lung cancer therapy.